(Q49985633)

English

Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease.

scientific article published on 15 February 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease. (English)

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Behçet's disease

0 references

1 reference

based on heuristic

inferred from title

intestinal tuberculosis

1 reference

based on heuristic

inferred from title

author name string

Shulan Zhang

1

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Jing Luo

2

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Ziyan Wu

3

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Dirk Roggenbuck

4

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Peter Schierack

5

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Dirk Reinhold

6

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Ji Li

7

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Xiaofeng Zeng

8

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Fengchun Zhang

9

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Jiaming Qian

10

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Yongzhe Li

11

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

publication date

15 February 2018

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Clinical and translational gastroenterology

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

9

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

2

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

e133

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Peripheral differentials by Cytodiff flow cytometric system predict disease activity in Chinese patients with inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Intestinal Behçet and Crohn's disease: two sides of the same coin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Autoimmunity in Crohn's Disease-A Putative Stratification Factor of the Clinical Phenotype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serologic Biomarkers in Chinese Patients With Crohn Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Diagnosis and classification of ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Diagnosis and classification of Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Inflammatory bowel disease serology in Asia and the West.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Glycoprotein 2 antibodies in Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Autoantibodies against exocrine pancreas in Crohn's disease are directed against two antigens: the glycoproteins CUZD1 and GP2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Identification of pancreatic glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Serological antibodies in inflammatory bowel disease: a systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Differentiating intestinal tuberculosis from Crohn's disease: a diagnostic challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Indeterminate colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Classification of inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Natural history of indeterminate colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

16 June 2018

Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

14 August 2018

Pancreatic Autoantibodies Against CUZD1 and GP2 Are Associated with Distinct Clinical Phenotypes of Crohn's Disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

14 August 2018

Species-specific and pathotype-specific binding of bacteria to zymogen granule membrane glycoprotein 2 (GP2).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

14 August 2018

Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

14 August 2018

Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

14 August 2018

Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

14 August 2018

Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5830545

30 November 2018

A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/29446764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to glycoprotein 2 (GP2) in patients with inflammatory bowel diseases from UK

1 reference

https://pubmed.ncbi.nlm.nih.gov/29446764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, in patients with gluten-sensitive enteropathy: a possible serological trap

1 reference

https://pubmed.ncbi.nlm.nih.gov/29446764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of tolerance to one or two major targets in Crohn's disease or just cross-reactivity?

1 reference

https://pubmed.ncbi.nlm.nih.gov/29446764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/29446764

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/CTG.2018.1

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

1 reference

Europe PubMed Central

16 June 2018

http://europepmc.org/abstract/PMC/5830545

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49985633&oldid=1534097167"